Strs Ohio Has $723,000 Position in CareDx, Inc (NASDAQ:CDNA)

Strs Ohio boosted its position in shares of CareDx, Inc (NASDAQ:CDNA) by 65.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 60,300 shares of the company’s stock after purchasing an additional 23,800 shares during the quarter. Strs Ohio’s holdings in CareDx were worth $723,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Nisa Investment Advisors LLC grew its holdings in CareDx by 442.5% during the fourth quarter. Nisa Investment Advisors LLC now owns 6,440 shares of the company’s stock valued at $77,000 after purchasing an additional 5,253 shares during the period. WINTON GROUP Ltd acquired a new position in shares of CareDx in the third quarter valued at approximately $72,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of CareDx by 23.2% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,751 shares of the company’s stock valued at $82,000 after buying an additional 2,211 shares during the period. Sherbrooke Park Advisers LLC acquired a new position in shares of CareDx in the third quarter valued at approximately $85,000. Finally, Principal Financial Group Inc. boosted its holdings in shares of CareDx by 14.3% in the third quarter. Principal Financial Group Inc. now owns 17,635 shares of the company’s stock valued at $123,000 after buying an additional 2,205 shares during the period.

Analysts Set New Price Targets

Separately, Stephens reiterated an “overweight” rating and issued a $15.00 price target on shares of CareDx in a report on Wednesday, April 17th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $13.50.

CareDx Trading Down 5.3 %

Shares of CDNA opened at $7.56 on Friday. CareDx, Inc has a 12 month low of $4.80 and a 12 month high of $12.93. The firm has a fifty day simple moving average of $9.62 and a 200 day simple moving average of $9.20. The stock has a market capitalization of $391.46 million, a price-to-earnings ratio of -2.14 and a beta of 1.42.

CareDx (NASDAQ:CDNA) last announced its earnings results on Wednesday, February 28th. The company reported ($2.21) EPS for the quarter, missing the consensus estimate of ($0.24) by ($1.97). CareDx had a negative return on equity of 51.40% and a negative net margin of 67.88%. The business had revenue of $65.57 million for the quarter, compared to analyst estimates of $63.66 million. During the same quarter in the previous year, the company posted ($0.34) EPS. The business’s revenue for the quarter was down 20.4% compared to the same quarter last year. As a group, research analysts predict that CareDx, Inc will post -1.59 earnings per share for the current fiscal year.

CareDx Profile

CareDx, Inc engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients.